Publications:

TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma.

Oncology Reports

Ye, Song S; Zhao, Xin-Yi XY; Hu, Xiao-Ge XG; Li, Tang T; Xu, Qiu-Ran QR; Yang, Huan-Ming HM; Huang, Dong-Sheng DS; Yang, Liu L

Publication Date: 2017-04

Variant appearance in text: VEGF: A113T

PubMed Link: 28350084

Variant Present in the following documents:

• Main text
• or-37-04-2215.pdf

View BVdb publication page